Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer.
For patients with compensated MASH-related cirrhosis and obesity, metabolic surgery associated with lower risk for adverse liver outcomes.
US internal medicine residents from ethnicities and races underrepresented in medicine remain underrepresented.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback